Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the current study is to investigate the efficacy, safety and tolerability of
BI 10773 at two different doses compared to placebo during long term treatment (78 weeks) in
combination with basal insulin in patients with type 2 diabetes mellitus with insufficient
glycaemic control.